Stockreport

AMAG Pharmaceuticals Commends CMS for Clarifying Part D Coverage of Treatments for Moderate to Severe Dyspareunia Due to Menopause

AMAG PHARMACEUTICALS  (AMAG) 
Last amag pharmaceuticals earnings: 3/4 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: amagpharma.com/investors
PDF WALTHAM, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today commended the recent action taken by the Centers for Medicare and Medic [Read more]